eISSN: 1509-572x
ISSN: 1641-4640
Folia Neuropathologica
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2010
vol. 48
 
Share:
Share:
abstract:

Original article
Free radical peroxidation products in cerebrospinal fluid and serum of patients with multiple sclerosis after glucocorticoid therapy

Krystyna Mitosek-Szewczyk
,
Wanda Gordon-Krajcer
,
Piotr Walendzik
,
Zbigniew Stelmasiak

Folia Neuropathologica 2010; 48 (2): 116-122
Online publish date: 2010/07/01
View full text Get citation
 
Multiple sclerosis (MS) patients were found to have elevated thiobarbituric acid reactive material levels, increased soluble sulfhydryl groups and reduced protein sulfhydryl groups in cerebrospinal fluid and serum, and slightly reduced superoxide dismutase in serum, which suggested disease activating free radical peroxidation. Moreover, levels of these varied across methylprednisolone (MP) therapy. We observed significant differences in the levels of peroxidation products between MS patients and controls. These changes were most evident in relapse. After MP therapy, levels of these indicators approached control values, especially in the remission period. Our findings suggest that MP protects against free radical attack.
keywords:

multiple sclerosis, glucocorticoid therapy, methylprednisolone, free radical peroxidation

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.